Deep Origin Says Its Physics-Plus-AI Platform Hit Cancer Drug Targets 100 Times More Often Than Standard Machine Learning
Computational drug discovery startup Deep Origin announced in mid-August 2026 that its AI platform achieved a 31% hit rate identifying...